ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2130

Post-fracture Survival for Rheumatoid Arthritis Patients Is Not Improving

Owen Taylor-Williams1, Johannes Nossent2 and Charles Inderjeeth3, 1University of Western Australia, Perth, Western Australia, Australia, 2University of Western Australia, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia, 3SCGH and OPH Group & University of Western Australia, Perth, Western Australia, Australia

Meeting: ACR Convergence 2024

Keywords: Clinical Osteoporosis, Disease-Modifying Antirheumatic Drugs (Dmards), Epidemiology, Fracture, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Improved disease control for articular manifestations of Rheumatoid arthritis (RA), has resulted in more attention being directed to extra-articular (ExRA) manifestations (cardiovascular events, osteoporosis, lung disease) which contribute to reduced survival. Osteoporosis (OP) is a common ExRA, notable for its risk of fractures, mortality, need for supportive care, chronic impairment, length of stay, and quality of life impairment. Despite this post-fracture outcomes in RA are not well studied.

Methods: We completed a matched cohort study using the West Australian Rheumatic Disease Epidemiology Register, which includes routinely collected longitudinal health data on rheumatoid patients seen in the West Australian hospital system as inpatients or ED patients. We included patient with at least one RA International Classification of Disease code (index date defined at first ICD code) and fracture code (excluding. skull, fingers, toes, and sternum). Post-fracture survival was analysed using Kaplan-Meyer and cox-regression analysis stratified into 1990-2000 (pre-disease modifying anti-rheumatic aka DMARD) and 2000-2010 (post-DMARD), and compared to a rheumatic-disease-free hospitalised cohort.

Results: 2,606 RA (79.3% female) and 3,449 matched controls (80.5% female) with fractures were included for analysis. Mean CCI at first fracture in RA was 1.67 (95% CI 1.59-1.75) vs 1.52 (95% CI 1.46-1.57) in controls (p >0.05). Five-year post-fracture survival in RA is 34.8% compared to 43.9% in controls (p< 0.001).  One-year post-fracture survival in RA decreased from 79.6% to 72.6% (1990-2000 to 2000-2010, p< 0.001). Fractures within one year of RA index were associated with worse survival (HR 3.17, 95% CI 1.08-9.29), compared to fractures 5-10 years post-RA-index. The association between time-to-fracture and post-fracture survival remained significant even after controlling for age, CCI, gender, and site of fracture (p=0.04).

Conclusion: Despite therapeutic advances, post-fracture survival for RA patients worsened between 1990 and 2010, possibly because patients have more severe illnesses, not accounted for in the CCI. Our other finding that shorter time from RA index to fracture is associated with worse post-fracture survival could result from patients with more active RA experiencing more rapid bone loss and more severe comorbidities, which result in earlier mortality. While more research must be done to understand both of these findings, we propose that shorter time to fracture from first RA presentation may be a risk factor for mortality after fracture.


Disclosures: O. Taylor-Williams: None; J. Nossent: None; C. Inderjeeth: None.

To cite this abstract in AMA style:

Taylor-Williams O, Nossent J, Inderjeeth C. Post-fracture Survival for Rheumatoid Arthritis Patients Is Not Improving [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/post-fracture-survival-for-rheumatoid-arthritis-patients-is-not-improving/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/post-fracture-survival-for-rheumatoid-arthritis-patients-is-not-improving/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology